Skip to main content
Full access
Letter to the Editor
Published Online: 1 February 2010

Stimulant Medication Use and Sudden Death in Youths: Considering Unmeasured Covariates

To the Editor: We would like to commend Dr. Gould et al. (1) on their study examining the association between the use of stimulants among youths and sudden death. We especially appreciated their extensive use of sensitivity analyses and the considerable detail they provided in Table 3, which married the systematic nature of a case-control study with the detail of a case series. This information allows several observations to be made. First, despite the inclusion of more general unexplained deaths, the majority of case subjects were ruled to have died from cardiac causes (dysrhythmia). Second, the activities (e.g., running, sleeping) of those who died of unknown causes were often similar to those of patients who died from dysrhythmias. Third, the authors provided information about concomitant drugs, and most case subjects (eight out of 10) were apparently receiving monotherapy. Fourth, toxicology appeared to have ruled out drug overdose as a likely factor in the majority of deaths.
However, in any case-control study, the comparability of the comparison subjects is crucial. This is especially true for this study, in which the observation of a single additional exposure in the comparison group (corresponding to small change in the stimulant use rate from 0.35% to 0.5%) would have substantially attenuated the observed relationship. It is therefore worth considering whether unappreciated differences in measured or unmeasured covariates plausibly could have caused stimulant use in the comparison group to be biased downward compared with the sudden death group. Among measured covariates, the authors achieved surprisingly good balance in age and year of death, despite using 3-year windows. However, in both these areas, the remaining imbalance, although small, favored lower stimulant use in the comparison group (slightly older age and a slightly earlier year of death). Among unmeasured covariates, could the authors possibly have analyzed the season of death if these data were already recorded, since seasonal differences likely exist in the probability of receiving a stimulant? It also seems to us, as supported by some literature, that juvenile accident victims might be expected to have lower income and live more often in rural settings, both circumstances associated in some (but not all) studies with lower rates of stimulant use. We would like to know the authors' opinion of whether these unmeasured covariates could have influenced their findings. Given the strength of the initial association, our expectation is that such factors might have attenuated, but not likely eliminated, the relationship between stimulant use and sudden death observed in this study. Lastly, we note that the weakest association was observed for the outcome that did not depend on informant reports, suggesting at least the possibility of recall bias favoring the recollection of stimulant use in the sudden death group.
In summary, the study represents a valuable contribution in this area, and we anticipate further studies examining the absolute risks and relative risks and, possibly, the predictors of adverse cardiac events during stimulant use.

Footnote

This letter was accepted for publication in October 2009.

Reference

1.
Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T: Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166:992–1001

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 213 - 214
PubMed: 20123922

History

Accepted: October 2009
Published online: 1 February 2010
Published in print: February 2010

Authors

Details

Ashwini Nadkarni, M.D.
Eric G. Smith, M.D., M.P.H.

Competing Interests

Dr. Smith receives funding for unrelated research from Forest Research Institute. Dr. Nadkarni reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share